ALS pathogenesis: recent insights from genetics and mouse models.

Area of Science:

• Neuroscience
• Genetics
• Biochemistry

Background:

• The etiology of most amyotrophic lateral sclerosis (ALS) cases remains unknown.
• Mutations in SOD1 and other genes (alsin, dynactin, senataxin, VAPB, TDP-43, FUS) have been linked to familial ALS.
• Transgenic mouse models have been crucial for studying ALS pathogenesis, revealing complex disease mechanisms.

Purpose of the Study:

• To describe newly generated TDP-43 transgenic mice.
• To discuss the validity of these TDP-43 transgenic mice as animal models for human ALS.
• To explore the pathological features of TDP-43 in ALS.

Main Methods:

• Generation of transgenic mice overexpressing wild-type (WT) or mutant TDP-43.
• Analysis of pathological features in TDP-43 transgenic mice.
• Comparison of TDP-43 mouse models with human ALS pathology.

Main Results:

• TDP-43 transgenic mice models have been developed with high-level overexpression of WT or mutant TDP-43.
• These models do not fully recapitulate all pathological features observed in human ALS.
• Studies on SOD1 mutant mice revealed toxicity unrelated to catalysis and highlighted roles for non-neuronal cells and cytoskeletal defects.

Conclusions:

• Newly developed TDP-43 transgenic mice offer insights into ALS pathogenesis.
• Further research is needed to fully validate TDP-43 mouse models for human ALS.
• Understanding TDP-43's role is critical for developing effective ALS therapies.